Mikrobiom und gastrointestinale Erkrankungen

Abstract

For some years, microbiome research has become a thriving topic. The most diverse and hitherto poorly understood connections of interactions of the microbiome with the host body (human) seem to play an important role in the genesis of a wide variety of diseases. This article focuses on the importance of the microbiome in gastrointestinal diseases and presents therapeutic approaches.

The intestinal microbiome will not be understood completely for a long time due to the highly complex relationships and variety of different microorganisms. The intestinal microbiome is critically involved in the development of diseases, especially in the development of inflammatory bowel disease. Helicobacter pylori infection is a major risk factor for gastric carcinoma. Esophageal microbiome alterations can cause inflammation and decrease the tone of the lower esophageal sphincter. Inflammation is a crucial pathway for tumorigenesis, it can be caused by the “normal” flora and by pathogenic agents. In the microbiome of the colon, interactions of bacteria, viruses and fungi have a very special status. Good oral/dental status protects against pancreatic carcinoma. Fecal microbiome transfer has become more important in the American guideline. Understanding the processes in the intestinal microbiome provides approaches to new therapies that are likely to exceed our current imagination.

Seit einigen Jahren hat sich die Mikrobiomforschung zu einem geradezu florierenden Themengebiet entwickelt. Die unterschiedlichsten und bislang wenig verstandenen Interaktionen des Mikrobioms mit dem Wirtskörper (Mensch) scheinen eine sehr große Rolle bei der Genese unterschiedlichster Krankheiten zu spielen. Dieser Beitrag stellt kompakt vor, was man inzwischen darüber weiß, was man vermutet und was z. B. ein fäkaler Mikrobiomtransfer zu leisten vermag.

Schlüsselwörter

FMT - CDAD - Pankreaskarzinom - FODMAP - Bakteriophagen

Key words

FMT - CDAD - pancreatic carcinoma - FODMAP - bacteriophages

• Literatur

• 1 Dominguez-Bello MG, Godoy-Vitorino F, Knight R. et al. Role of the microbiome in human development. Gut 2019; DOI: 10.1136/gutjnl-2018-317503.
• 2 Bik EM, Eckburg PB, Gill SR. et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006; 103: 732-737
• 3 Ma JL, Zhang L, Brown LM. et al. Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and Mortality. J Natl Cancer Inst 2012; 104: 488-492
• 4 Abreu NT, Peek Jr RM. Gastrointestinal Malignancy and the Microbiome. Gastroenterol 2014; 146: 1534-1546.e3
• 5 Pei Z, Bini EJ, Yang L. et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA 2004; 101: 4250-4255
• 6 Ajayi TA, Cantrell S, Spann A. et al. Barrett’s esophagus and esophageal cancer: Links to microbes and the microbiome. PLoS Pathog 2018; 14: e1007384 . doi:10.1371/journal.ppat.1007384
• 7 Belcheva A, Irrazabal T, Robertson SJ. et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 2014; 158: 288-299
• 8 Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899
• 9 Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol 2017; 32: 43-53
• 10 Chudnovskiy A, Mortha A, Kana V. et al. Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. Cell 2016; 167: 444-456.e14
• 11 Karpiński TM. Role of Oral Microbiota in Cancer Development. Microorganisms 2019; 7 DOI: 10.3390/microorganisms7010020.
• 12 Ertz-Archambault N, Keim P, von Hoff D. Microbiome and pancreatic cancer: A comprehensive topic review of literature. World J Gastroenterol 2017; 23: 1899-1908
• 13 Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078
• 14 Elinav E, Strowig T, Kau AL. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745-757
• 15 Albenberg L, Esipova TV, Judge CP. et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014; 147: 1055-1063.e8
• 16 Derwa Y, Gracie DJ, Hamlin PJ. et al. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 2017; 46: 389-400
• 17 Costello SP, Soo W, Bryant RV. et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther 2017; 46: 213-224
• 18 Paramsothy S, Kamm MA, Kaakoush NO. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet Lond Engl 2017; 389: 1218-1228
• 19 De Palma G, Lynch MDJ, Lu J. et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med 2017; 9 DOI: 10.1126/scitranslmed.aaf6397.
• 20 Tap J, Derrien M, Törnblom H. et al. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology 2017; 152: 111-123.e8
• 21 El-Salhy M, Mazzawi T, Hausken T. et al. Interaction between diet and gastrointestinal endocrine cells. Biomed Rep 2016; 4: 651-656
• 22 McDonald LC, Gerding DN, Johnson S. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66: e1-e48 . doi:10.1093/cid/cix1085
• 23 Quraishi MN, Widlak M, Bhala N. et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther 2017; 46: 479-493 . doi:10.1111/apt.14201
• 24 Ott SJ, Waetzig GH, Rehman A. et al. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology 2017; 152: 799-811.e7